Agitation Management
Psychiatry Editors: Claire Willman, MD and Idil Yazgan, MD
Reviewed by: Jonathan Smith, MD and Daniel Daunis, MD
Section Editor: Claire Willman
Background
- Agitation in the hospital can result from many different reasons and may include irritability, anxiety, pacing, yelling, sexually inappropriate behavior, pulling at restraints or medical devices, among others.
- Aggression is a specific form of agitation in which the person is threatening or attempting to harm another person or physical objects.
Presentation
- Impulsive aggression: spontaneous, explosive, reactive/reflexive, not pre-meditated.
- Instrumental aggression: pre-meditated, controlled, purposeful behaviors.
Differential diagnosis for aggression
- Personality disorder: antisocial, borderline, paranoid, narcissistic.
- Secondary gain
- Delirium
- Dementia/cognitive deficits
- Psychosis
- Mania
- Substance use disorder: both intoxication and withdrawal states from alcohol, PCP, stimulants, cocaine, synthetics.
- Frontal lobe syndromes (TBI, CVA, neoplasm, neurodegenerative process).
- Behavior/Developmental: Intermittent explosive disorder, intellectual disability including autism spectrum disorder.
- Pain.
Evaluation
- Examine (when calm) for source of pain, signs of infection, discomfort (ex: urinary retention or constipation), toxidromes.
- Neurological exam for focal deficits, ataxia, nystagmus, tremor, rigidity, aphasias.
- Review medication list and perform med reconciliation of home meds.
- Recent medication changes including recently started medications and home medications that have been held or recently discontinued.
- UDS + review of CSMD for evaluation of intoxication/withdrawal.
- Keep in mind limitations of sensitivity and specificity of immunoassay trained against specific epitopes.
- Opiate antibodies commonly have codeine and morphine as their target analytes and will not detect fentanyl and many other synthetic or semisynthetic opioids that are structurally distinct from morphine.
- Benzodiazepines antibodies commonly have oxazepam (diazepam and chlordiazepoxide metabolite) as a target analyte with poor cross sensitivity to lorazepam and clonazepam.
- Amphetamines broadly include commonly prescribed stimulants used to treat ADHD as well as methamphetamine.
- Keep in mind limitations of sensitivity and specificity of immunoassay trained against specific epitopes.
- CBC, CMP, UA.
- CT head + EEG if focal neurologic deficits.
- For evaluation of AMS, typically order only non-contrasted CTH, may follow up with contrasted MRI.
Management
- Environment
- Periodic room searches; search or remove personal belongings, VUPD presence if warranted.
- Virtual or 1:1 sitter placement; unit can obtain CSO sitter for high risk patients.
- Delirium precautions (see delirium section).
- Disposable trays and utensils (minimize potential weapons in the room).
- Medication reconciliation
- Reduce or eliminate anticholinergic load and other deliriogenic medications (see delirium).
- De-escalation: Always first line and best if attempted early when patient is anxious or irritable, although impractical if patient is unable to communicate effectively, is explosive or already engaging in violent/potentially harmful behavior.
- Nonverbal:
- Keep yourself between the patient and the door to allow exit if needed.
- Maintain safe distance, avoid sudden movements, don't touch the patient.
- Maintain neutral posture, sincere eye contact.
- Verbal:
- Speak in calm, clear tone, avoid confrontation, and offer to solve problem if possible.
- Do not insist on having the last word and try to not take provocations personally.
- See MI section on “OARS” for strategies.
- Redirection: Acknowledge patient's frustrations, shift focus on how to solve the problem.
- Aligning goals: Emphasize common ground and big picture; make small concessions; what can you and the patient agree on?
- Restraints
- Should be used only when necessary to protect patient or others from harm.
- Mechanically restrained patients cannot be left unmonitored and must have a virtual or in person sitter ordered.
- De-escalate (4 point to 2 point, etc.) and remove restraints as soon as possible.
- Documentation of restraint: Face-to-face assessment has to be completed and documented within an hour of initiation of restraint.
- Found in Epic under, “Restraint Charting” tab – typically in rarely used tab drop down.
- Mechanical Restraints:
- Soft restraints (non-violent) – most commonly used.
- Hard restraints (violent) – reserved for severe behavioral health (only 2 sets in house).
- Mittens.
- Posey Vest – prevents exiting bed, allows limbs to be free, can be attached to bedside recliners.
- Posey Bed – wandering patient (TBI, severe dementia).V
- VUMC Orders: “restraint” → order set.
- Non-violent non-self-destructive (order lasts up to 48 hrs.) Most patient’s needing restraint: non-psychiatric, delirium, dementia, intubation.
- Violent self-destructive adult. Order lasts up to 24hr with assessment every 4 hours. Mainly for severe psychiatric symptoms.
- Nonverbal:
Pharmacological Management for Agitation
As discussed above, behavioral interventions are first line for agitation management in the hospital. Pharmacologic treatment should only be used when needed for patient and/or staff safety when non-pharmacologic interventions are unsuccessful or impractical. Not all forms of agitation can be treated pharmacologically, but all forms of aggression toward staff need to be addressed immediately.
Acute Agitation
Antipsychotics
- Widely effective for acute agitation, especially in delirium and psychotic disorders/ Monitor EKG if repeated dosing or if used with other QT prolonging agents (and utilize QTcF, not QTcB).
- Estimated QTcB on standard EKGs is artificially increased in the setting of tachycardia and overestimates the number of patients with a potentially dangerous QTc prolongation.
- Bradycardia is a significant risk factor for TdP.
- Tachycardia is somewhat protective from TdP.
Moderate agitation options
- Olanzapine 2.5 - 5mg po q6h prn. Orally disintegrating tab (ODT) available.
- Quetiapine 12.5 - 25mg q6h po prn for patients at higher risk of extrapyramidal symptoms (EPS).
Severe agitation
- Haloperidol 0.5 - 1mg IV/IM q6h prn for older/frail individuals.
- Haloperidol 2-3mg IV/IM q6h prn for other patients.
- Titrate up to 5-10 mg and can increase frequency as warranted.
- When using IV haloperidol obtain daily EKG, Mg and K levels should be kept above 2 and 4, respectively.
- Stop IV haloperidol if QTcF > 500 msec.
Benzodiazepines
- Lacks EPS that can occur with antipsychotics but can worsen delirium & disinhibit patients with neurocognitive-related agitation.
- First choice for agitation without clear etiology or in patients with severe aggression.
- Can use alone or in addition to antipsychotic agent.
- Preferred for agitation related to intoxication/withdrawal of sedatives.
- Lorazepam preferentially used due to PO, IV and IM availability.
- Lorazepam 2mg PO/IM/IV q6h prn typical starting dose (1mg if older/frail)
- Can increase frequency if warranted. Monitor for respiratory suppression.
- If severe agitation not responsive to above, may require ICU admission and sedation:
- Dexmedetomidine (preferred), propofol or midazolam.
Maintenance medications
- Antipsychotics
- Reserve scheduled antipsychotics for aggression that poses significant risk and aim to wean as soon as safely possible.
- Adverse effects: metabolic, EPS, increased mortality in dementia.
- Most commonly used: olanzapine, quetiapine, risperidone.
- Antiepileptic agents
- May be effective in reduction of impulsive aggression in TBI or dementia.
- .Most commonly used: Valproate.
- Levetiracetam could worsen aggression/agitation.
- Beta Blockers and Alpha Agonists
- Noradrenergic over-activity implicated in aggression expression (think adrenaline spike + confusion).
- Commonly Used: propranolol, clonidine, guanfacine.
- Serotonergic agents: SSRI/SNRI/buspirone
- Useful if co-occurring depression/anxiety disorders.
- Peak onset of action takes weeks.
